Correlation Between Suzhou Novoprotein and Maccura Biotechnology

Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Maccura Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Maccura Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Maccura Biotechnology Co, you can compare the effects of market volatilities on Suzhou Novoprotein and Maccura Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Maccura Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Maccura Biotechnology.

Diversification Opportunities for Suzhou Novoprotein and Maccura Biotechnology

0.88

Correlation Coefficient

Suzhou Novoprotein  Maccura Biotechnology

Very poor diversification

The 3 months correlation between Suzhou and Maccura is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Maccura Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maccura Biotechnology and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Maccura Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maccura Biotechnology has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Maccura Biotechnology go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Maccura Biotechnology

Assuming the 90 days trading horizon Suzhou Novoprotein Scientific is expected to under-perform the Maccura Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Suzhou Novoprotein Scientific is 1.01 times less risky than Maccura Biotechnology. The stock trades about -0.49 of its potential returns per unit of risk. The Maccura Biotechnology Co is currently generating about -0.43 of returns per unit of risk over similar time horizon. If you would invest  1,420  in Maccura Biotechnology Co on October 8, 2024 and sell it today you would lose (157.00) from holding Maccura Biotechnology Co or give up 11.06% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Suzhou Novoprotein Scientific  vs.  Maccura Biotechnology Co

Suzhou Novoprotein

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Suzhou Novoprotein Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Maccura Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Maccura Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Suzhou Novoprotein and Maccura Biotechnology

The main advantage of trading using opposite Suzhou Novoprotein and Maccura Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Maccura Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maccura Biotechnology will offset losses from the drop in Maccura Biotechnology's long position.

The idea behind Suzhou Novoprotein Scientific and Maccura Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.